<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">0</item><item key="sample_count">92</item><item key="tags"><item>cancer</item><item>carcinoma</item><item>cell</item><item>clear cell</item><item>disease</item><item>kidney</item><item>membrane</item><item>oncocytoma</item><item>rcc</item><item>transitional</item><item>transitional cell</item><item>transitional cell carcinoma</item></item><item key="slug">gene-signatures-of-progression-and-metastasis-in-r</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-15641</item><item key="species">human</item><item key="id">1439</item><item key="name">Gene signatures of progression and metastasis in renal cell cancer</item></item><item><item key="factor_count">0</item><item key="sample_count">30</item><item key="tags"><item>bladder cancer</item><item>cancer</item><item>carcinoma</item><item>cell</item><item>transitional</item><item>transitional cell</item><item>transitional cell carcinoma</item><item>urothelium</item></item><item key="slug">transcription-profiling-of-human-advanced-bladder</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-5287</item><item key="species">human</item><item key="id">1623</item><item key="name">Transcription profiling of human advanced bladder cancer to predict response and survival following chemotherapy in patients</item></item><item><item key="factor_count">2</item><item key="sample_count">60</item><item key="tags"><item>bladder cancer</item><item>cancer</item><item>carcinoma</item><item>cell</item><item>disease</item><item>muscle</item><item>superficial</item><item>transitional</item><item>transitional cell</item><item>transitional cell carcinoma</item><item>urinary bladder</item><item>urothelium</item></item><item key="slug">transcription-profiling-of-human-urinary-superfici</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-3167</item><item key="species">human</item><item key="id">1717</item><item key="name">Transcription profiling of human urinary superficial transitional cell carcinoma with surrounding carcinoma in situ (CIS) lesions, without surrounding CIS lesions, and muscle invasive carcinoma</item></item></data></biogps>
